Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock Analysis

Dr. Reddy’s Laboratories Ltd ADR (RDY) is a publicly traded company in the HEALTHCARE sector. It trades at $13.04, carries a market capitalization of $11.38B, a price-to-earnings ratio of 25.72. This page summarizes the public market data, fundamentals, and frequently asked questions for RDY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

Market Sentiment

Dr. Reddy’s Laboratories Ltd ADR currently has a Bullish sentiment score of 0.25.

About Dr. Reddy’s Laboratories Ltd ADR

Dr. Reddy's Laboratories Ltd (ADR) is a leading global pharmaceutical company based in Hyderabad, India, known for its comprehensive portfolio of generic medicines, proprietary drugs, and active pharmaceutical ingredients. With a strong focus on research and development, Dr. Reddy's fosters innovation across various therapeutic segments while maintaining a robust supply chain to serve markets worldwide. The company's commitment to providing high-quality, affordable healthcare solutions underl...

GNG Research Analysis

GNG Research scores Dr. Reddy’s Laboratories Ltd ADR (RDY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RDY.

Frequently Asked Questions

Does RDY pay dividends?

Dr. Reddy’s Laboratories Ltd ADR (RDY) does not currently pay a regular dividend.

What is RDY's P/E ratio?

Dr. Reddy’s Laboratories Ltd ADR has a price-to-earnings (P/E) ratio of 25.72.

What is RDY's market cap?

Dr. Reddy’s Laboratories Ltd ADR (RDY) has a market capitalization of $11.38B with a current stock price of $13.04.